Net Contents
30 Capsule(s)
Serving Size
1 Capsule(s)
Servings Per Container
30
Supplement Form
Capsule
Bar Code (UPC/SKU)
Not specified
Product Version
300-HEPCC-A
Label Analysis
Objective insights generated automatically from the official DSLD label — a quick, factual read of how this product is formulated and disclosed.
Single-ingredient formula listed in Supplement Facts.
Every active ingredient discloses a specific amount per serving.
This analysis is generated algorithmically from label data for educational reference only. It is not a product endorsement, ranking, or medical advice.
Supplement Facts
Serving Size: 1 Capsule(s) · 1 per day
| Ingredient | Amount Per Serving | |
|---|---|---|
| Dried Yeast Fermentate | 500 mg | — |
Not Present
Other Ingredients
Target Groups
Label Claims
Directions & Suggested Use
Suggested/Recommended/Usage/Directions
Suggested Use: Take one capsule daily.
Warnings & Precautions
Precautions re: Children
KEEP OUT OF REACH OF CHILDREN.
Precautions re: All Other
Caution: If you are taking medication or have a medical condition, consult with your healthcare professional before taking this or any other dietary supplement.
Storage
Storage
STORE IN A COOL, DRY PLACE.
FDA Statements
FDA Statement of Identity
Dietary Supplement
FDA Disclaimer Statement
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent and disease.
Other Label Statements
General: Product/Version Code
300-HEPCC-A
General Statements: All Other Content
Contains the World’s Finest Ingredients.
General Statements: All Other Content
Immune System Support*
General Statements: All Other Content
This product is manufactured in a NSF GMP registered facility.
Seals/Symbols
MADE IN USA
Brand IP Statement(s) re: (c), (TM), (SM)
EpiCor(R) is a registered trademark of Embria Health Sciences, Cedar Rapids, IA, USA.
Manufacturer & Distributor
Distributor
Health Resources(TM)
P.O. Box 3623, Hueytown, AL, 35023
1-800-471-4007
Market Reference
Epicor Healthy Origins
Healthy Origins USA4.8(159)$22.99EpiCor Capsules 180ct. 500mg
Nootropics Depot$29.99Epicor
Gluten-Free Remedies$35.00Source Naturals EpiCor with Vitamin D-3
Swanson Health Products4.8(122)$25.49EpiCor Dietary Supplement Capsules 180 ct
Hy-Vee$69.99EpiCor 500 mg 90c
Renewed Vitality Dallas TX$74.00NOW Foods EpiCor Plus 60 Veg Capsules
NOW4.7(195)$36.99Swanson Rapid Epicor 500 mg 30 Capsules
Swanson Health Products4.7(265)$17.49
Where to Buy Locally
Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.
Research & Studies
Prehospital and in-hospital use of healthcare resources in patients surviving acute coronary syndromes: an analysis of the EPICOR registry
L Annemans, N Danchin, F Van de Werf, S Pocock… - Open …, 2016 - openheart.bmj.com
… healthcare resource use (HCRU) during the critical management of patients surviving acute coronary syndromes (ACS), using data from EPICOR (… Methods EPICOR was a prospective, …
201611 citationsEPICOR (long-tErm follow-up of antithrombotic management Patterns In acute CORonary syndrome patients) study: rationale, design, and baseline characteristics
H Bueno, N Danchin, M Tafalla, C Bernaud… - American heart …, 2013 - Elsevier
… of quality of life and health resources consumption, the rates of … multiplied by the frequency of occurrence of these resources. … Factors related to healthcare resources consumption and …
201352 citationsRationale, design, and baseline characteristics of the EPICOR Asia study (Long‐tErm follow‐uP of antithrombotic management patterns In Acute CORonary Syndrome …
Y Huo, SWL Lee, JPS Sawhney, HS Kim… - Clinical …, 2015 - Wiley Online Library
… outcomes, healthcare resource use, and self-reported health status… evident between the EPICOR Asia and EPICOR (performed in … /regions in EPICOR Asia, in public healthcare systems, …
201542 citationsPredictors of high-cost hospitalization in the treatment of acute coronary syndrome in Asia: findings from EPICOR Asia
S Jan, SWL Lee, JPS Sawhney, TK Ong… - BMC cardiovascular …, 2018 - search.proquest.com
… Such reforms, while critical in promoting social protection and equity of access to healthcare, come with significant resource requirements and will inevitably magnify future health sector …
201828 citations… patients in Belgium and Luxembourg and other Western European countries: a subset analysis of results from the observational, longitudinal cohort study EPICOR
C Beauloye, M Vrolix, MJ Claeys, PVD Borne… - Acta …, 2016 - Taylor & Francis
… Methods and results EPICOR (NCT01171404) is a multinational, observational study comprising patients with acute coronary syndrome hospitalized within 24 h of symptoms onset, …
20166 citationsContemporary inter-hospital transfer patterns for the management of acute coronary syndrome patients: Findings from the EPICOR study
PR Sinnaeve, U Zeymer, H Bueno… - … Heart Journal: Acute …, 2015 - academic.oup.com
… resources. In this paper, we report on the initial baseline patient-based transfer strategies in the EPICOR … analysis are also likely to reflect regional differences in healthcare organization. …
201526 citations
Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2012-01-25. DSLD Label ID: 4765. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.



